Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Haslam

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Thorax|December 1, 1986
Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?M Turner-Warwick, W McAllister, R Lawrence, et al.
Thorax|February 1, 1983
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimensE D Bateman, M Turner-Warwick, P L Haslam, et al.
Clinical and Experimental Immunology|July 1, 1985
Immune function and survival in pleural mesotheliomaM R Law, M J Smith, C Millband, et al.
Chest|September 1, 1995
The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeabilityD G Sinclair, P L Haslam, G J Quinlan, et al.
Thorax|October 1, 1984
Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevanceJ M Kirk, E D Bateman, P L Haslam, et al.
Thorax|August 1, 1990
Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosisN K Harrison, R J McAnulty, P L Haslam, et al.
Archives of Environmental Health|May 1, 1986
Identification of inorganic dust particles in bronchoalveolar lavage macrophages by energy dispersive x-ray microanalysisN F Johnson, P L Haslam, A Dewar, et al.
Clinical and Experimental Immunology|July 1, 1982
Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis)P L Haslam, F Allan, A F Watling, et al.
Lancet (London, England)|April 23, 1994
Surfactant replacement therapy in late-stage adult respiratory distress syndromeP L Haslam, D A Hughes, P D MacNaughton, et al.
Clinical Allergy|September 1, 1981
Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitisR M du Bois, P J Townsend, P J Cole, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Thorax|December 1, 1986
Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?M Turner-Warwick, W McAllister, R Lawrence, et al.
Thorax|February 1, 1983
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimensE D Bateman, M Turner-Warwick, P L Haslam, et al.
Clinical and Experimental Immunology|July 1, 1985
Immune function and survival in pleural mesotheliomaM R Law, M J Smith, C Millband, et al.
Chest|September 1, 1995
The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeabilityD G Sinclair, P L Haslam, G J Quinlan, et al.
Thorax|October 1, 1984
Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevanceJ M Kirk, E D Bateman, P L Haslam, et al.
Thorax|August 1, 1990
Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosisN K Harrison, R J McAnulty, P L Haslam, et al.
Archives of Environmental Health|May 1, 1986
Identification of inorganic dust particles in bronchoalveolar lavage macrophages by energy dispersive x-ray microanalysisN F Johnson, P L Haslam, A Dewar, et al.
Clinical and Experimental Immunology|July 1, 1982
Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis)P L Haslam, F Allan, A F Watling, et al.
Lancet (London, England)|April 23, 1994
Surfactant replacement therapy in late-stage adult respiratory distress syndromeP L Haslam, D A Hughes, P D MacNaughton, et al.
Clinical Allergy|September 1, 1981
Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitisR M du Bois, P J Townsend, P J Cole, et al.
Pageof 7